{
    "Trade/Device Name(s)": [
        "Great Basin Bordetella Direct Test",
        "Bordetella Test"
    ],
    "Submitter Information": "Great Basin Scientific, Inc.",
    "510(k) Number": "K170284",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133673"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZZ",
        "OOI"
    ],
    "Summary Letter Date": "March 31, 2017",
    "Summary Letter Received Date": "January 30, 2017",
    "Submission Date": "January 26, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Bordetella pertussis DNA"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Viral Transport Media (VTM)",
        "Liquid Amies (ESwab)",
        "Liquid Stuart transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "PA500 Portrait Analyzer",
        "Portrait Optical Reader",
        "Portrait Data Analysis Software Program"
    ],
    "Method(s)/Technology(ies)": [
        "PCR amplification",
        "Automated hot-start PCR",
        "Colorimetric hybridization on silicon chip",
        "Optical detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "PCR",
        "DNA hybridization"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Analyzer",
        "Cartridge",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Great Basin Bordetella Direct Test, an automated PCR-based qualitative assay for detection of Bordetella pertussis DNA in nasopharyngeal swab specimens.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for detection of Bordetella pertussis DNA from nasopharyngeal swab specimens obtained from patients suspected of having a respiratory tract infection attributable to B. pertussis.",
    "fda_folder": "Microbiology"
}